ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.
Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...
Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...
The Brighterside of News on MSN
Scientists solve the evolutionary mystery of how humans came to walk upright
The pelvis is often called the keystone of upright movement. It helps explain how human ancestors left life on all fours ...
Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...
India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
The findings are particularly relevant for India, where colorectal cancer is emerging as a growing public health concern ...
Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback